Coya Tapia

Coya Tapia has a diverse work experience in the field of medicine. Coya is currently working as a Medical Director at Bolt Biotherapeutics, Inc. since July 2022. Prior to this, they worked at Epizyme as a Medical Director and Director of Translational Medicine from March 2022 to June 2022, and as a Director of Clinical and Translational Medicine from January 2020 to March 2022. Before joining Epizyme, they held the position of Assistant Professor at the University of Texas MD Anderson Cancer Center from May 2015 to January 2020. Coya also worked as an Attending Pathologist at the University of Bern from July 2011 to December 2014, and at the University of Basel in Switzerland from July 2008 to June 2011.

Coya Tapia completed their education from 1992 to 1998 at the University of Basel in Switzerland, where they earned their degree in Medicine. Coya obtained a Doctor of Medicine (MD) degree during this period. Coya'sfield of study focused on Medicine.